Key statistics
As of last trade Insulet Corp (GOV:FRA) traded at 207.90, 3.18% above its 52-week low of 201.50, set on Feb 13, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 205.60 |
|---|---|
| High | 208.20 |
| Low | 205.60 |
| Bid | 209.00 |
| Offer | 209.50 |
| Previous close | 208.30 |
| Average volume | 58.29 |
|---|---|
| Shares outstanding | 70.40m |
| Free float | 69.91m |
| P/E (TTM) | 70.45 |
| Market cap | 17.36bn USD |
| EPS (TTM) | 3.50 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 17:00 GMT.
More ▼
- Insulet Reports Fourth Quarter and Full Year 2025 Results
- Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care
- Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026
- Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health
- Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference
- Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future
- Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
More ▼
